Tekzima Drug Alborz

Tekzima Drug Alborz is an Iranian biopharmaceutical company founded in 2016 that specializes in the development and manufacturing of high-tech biologics for critical care and neonatology. The company is a subsidiary of Noargen Biopharma and is best known for its flagship product, Beraksurf (beractant), which is the first Iranian-made natural bovine-derived pulmonary surfactant. Beraksurf is a biosimilar of Survanta and is widely used to treat Infant Respiratory Distress Syndrome (IRDS) in premature neonates, while also being investigated for adult ARDS and COVID-19 related lung injuries. Based in the Alborz province, Tekzima focuses on providing cost-effective, high-quality alternatives to imported life-saving medications for the domestic and regional markets.